Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Establishing Clinical Utility Evidence for a Novel Alzheimer's Disease Blood-Based Biomarker Assay: A QURE Virtual Patient Randomized Controlled Trial

NCT07099001 is registered in ClinicalTrials.gov with Qure Healthcare, LLC as lead sponsor.

NCT NCT07099001
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07099001 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Establishing Clinical Utility Evidence for a Novel Alzheimer's Disease Blood-Based Biomarker Assay: A QURE Virtual Patient Randomized Controlled Trial
Lead sponsor
Qure Healthcare, LLC
Phase
Not applicable
Overall status
Completed
Start date
August 8, 2025
Completion date
December 31, 2025
Enrollment
178 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease (ad), cognitive decline